#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials episode artwork

EPISODE · Sep 24, 2021

#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

from Breakpoints

Pathogen-directed trials are among the most important trials that clinicians need to guide therapy but are also incredibly difficult to design and enroll. Rachel Britt (@RachelBPharmD) gets a behind-the-scenes interview with Adam Stewart (@adm_stewart), lead investigator of MERINO-2, and Jason Pogue (@jpogue1), lead investigator of OVERCOME. They discuss original intentions and evolving expectations to investigate optimal antibiotic therapy for multidrug resistant bacteria. Listen in for the insider analysis! Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

Episode metadata supplied by the publisher feed · Published Sep 24, 2021

Embed this episode

Ready to play

#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

When was this Breakpoints episode published?

This episode was published on September 24, 2021.

Can I download this Breakpoints episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!